• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-221 通过靶向 PHF2 促进肝癌细胞迁移。

MiR-221 Promotes Hepatocellular Carcinoma Cells Migration via Targeting PHF2.

机构信息

Department of Human Anatomy, Histology and Embryology, School of Biology and Basic Medical Sciences, Soochow University, Suzhou 215007, China.

School of Medicine, Yangzhou University, Yangzhou 225001, China.

出版信息

Biomed Res Int. 2019 May 12;2019:4371405. doi: 10.1155/2019/4371405. eCollection 2019.

DOI:10.1155/2019/4371405
PMID:31214616
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6535842/
Abstract

MicroRNAs (MiRNAs), which regulate the gene expression leading to translational inhibition or mRNA degradation, are involved in carcinogenesis and tumor progression. Previous studies have demonstrated that miR-221 was one of the most consistent overexpressed miRNAs in several types of cancer. However, the role of miR-221 in human liver cancer progression is not yet fully elucidated. Levels of miR-221 and plant homeodomain finger 2 (PHF2) expressions in human hepatocellular carcinoma (HCC) tissues and cell lines were detected using western blotting and quantitative real-time PCR (qRT-PCR). Cell migration was studied using the transwell assays. A dual-luciferase reporter system was used to validate the target gene of miR-221. The results indicated that miR-221 promoted HCC cell migration. By performing subsequent systematic bioinformatic analyses, we found PHF2 was the target gene of miR-221 and the direct binding relationship was further validated by dual-luciferase reporter assay. In addition, lower expression of PHF2 promoted HCC cell migration and linked to worse overall survival in HCC patients. Finally, the negative correlation between miR-221 and PHF2 expression levels in HCC specimens was further confirmed. Taken together, our findings implied that miR-221 could be a potential candidate for the therapeutics of HCC metastasis.

摘要

微小 RNA(miRNAs)通过调控导致翻译抑制或 mRNA 降解的基因表达,参与了癌症的发生和肿瘤的进展。先前的研究表明,miR-221 是几种类型癌症中最一致过表达的 miRNA 之一。然而,miR-221 在人类肝癌进展中的作用尚未完全阐明。通过 Western blot 和定量实时 PCR(qRT-PCR)检测人肝癌(HCC)组织和细胞系中 miR-221 和植物同源域指 2(PHF2)的表达水平。使用 Transwell 测定法研究细胞迁移。双荧光素酶报告系统用于验证 miR-221 的靶基因。结果表明,miR-221 促进了 HCC 细胞迁移。通过进行后续的系统生物信息学分析,我们发现 PHF2 是 miR-221 的靶基因,双荧光素酶报告实验进一步验证了这种直接的结合关系。此外,PHF2 的低表达促进了 HCC 细胞迁移,并与 HCC 患者的总体生存率降低相关。最后,进一步证实了 HCC 标本中 miR-221 和 PHF2 表达水平之间的负相关关系。总之,我们的研究结果表明,miR-221 可能是 HCC 转移治疗的潜在候选物。

相似文献

1
MiR-221 Promotes Hepatocellular Carcinoma Cells Migration via Targeting PHF2.miR-221 通过靶向 PHF2 促进肝癌细胞迁移。
Biomed Res Int. 2019 May 12;2019:4371405. doi: 10.1155/2019/4371405. eCollection 2019.
2
MiR-369-5p inhibits the proliferation and migration of hepatocellular carcinoma cells by down-regulating HOXA13 expression.miR-369-5p 通过下调 HOXA13 表达抑制肝癌细胞的增殖和迁移。
Tissue Cell. 2022 Feb;74:101721. doi: 10.1016/j.tice.2021.101721. Epub 2021 Dec 27.
3
MicroRNA-500a Promotes the Progression of Hepatocellular Carcinoma by Post-Transcriptionally Targeting BID.微小RNA-500a通过转录后靶向BID促进肝细胞癌进展。
Cell Physiol Biochem. 2018;47(5):2046-2055. doi: 10.1159/000491472. Epub 2018 Jul 3.
4
MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma.miR-450b-3p 通过靶向磷酸甘油酸激酶 1 抑制肝癌细胞生长。
J Cell Biochem. 2019 Nov;120(11):18805-18815. doi: 10.1002/jcb.29196. Epub 2019 Jun 21.
5
microRNA-18a Promotes Cell Migration and Invasion Through Inhibiting Dicer l Expression in Hepatocellular Carcinoma In Vitro.微小RNA-18a通过抑制Dicer 1表达促进体外肝癌细胞迁移和侵袭
Chin Med Sci J. 2017 Apr 10;32(1):34-3. doi: 10.24920/j1001-9242.2007.005.
6
miR-142-3p Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Regulating HMGB1 Gene Expression.微小RNA-142-3p通过调控高迁移率族蛋白B1基因表达抑制肝癌细胞转移。
Curr Mol Med. 2018;18(3):135-141. doi: 10.2174/1566524018666180907161124.
7
Long Non-Coding RNA MALAT1 Regulates ZEB1 Expression by Sponging miR-143-3p and Promotes Hepatocellular Carcinoma Progression.长链非编码RNA MALAT1通过海绵吸附miR-143-3p调控ZEB1表达并促进肝细胞癌进展。
J Cell Biochem. 2017 Dec;118(12):4836-4843. doi: 10.1002/jcb.26158. Epub 2017 Jun 13.
8
miR-206 inhibits cell proliferation, invasion, and migration by down-regulating PTP1B in hepatocellular carcinoma.miR-206 通过下调肝癌中的 PTP1B 抑制细胞增殖、侵袭和迁移。
Biosci Rep. 2019 May 15;39(5). doi: 10.1042/BSR20181823. Print 2019 May 31.
9
miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.微小RNA-139-5p通过靶向锌指E盒结合蛋白1和锌指E盒结合蛋白2抑制肝癌细胞的上皮-间质转化、迁移和侵袭。
Biochem Biophys Res Commun. 2015 Jul 31;463(3):315-21. doi: 10.1016/j.bbrc.2015.05.062. Epub 2015 May 27.
10
Upregulation of RASAL2 promotes proliferation and metastasis, and is targeted by miR-203 in hepatocellular carcinoma.RASAL2的上调促进增殖和转移,并且在肝细胞癌中受到miR-203的靶向作用。
Mol Med Rep. 2017 May;15(5):2720-2726. doi: 10.3892/mmr.2017.6320. Epub 2017 Mar 14.

引用本文的文献

1
The emerging roles of histone demethylases in cancers.组蛋白去甲基化酶在癌症中的新兴作用。
Cancer Metastasis Rev. 2024 Jun;43(2):795-821. doi: 10.1007/s10555-023-10160-9. Epub 2024 Jan 16.
2
miRNA and lncRNA as potential tissue biomarkers in hepatocellular carcinoma.微小RNA和长链非编码RNA作为肝细胞癌潜在的组织生物标志物
Noncoding RNA Res. 2023 Oct 24;9(1):24-32. doi: 10.1016/j.ncrna.2023.10.010. eCollection 2024 Mar.
3
Bioinformatic analysis shows the correlation of hsa_circ_0006220-miR-221/222-3p-ESR1/KDR axis with sorafenib resistance of hepatocellular carcinoma.

本文引用的文献

1
Oncogenic miR-425-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.致癌性miR-425-5p与肾细胞癌的细胞迁移、增殖和凋亡相关。
Oncol Lett. 2018 Aug;16(2):2175-2184. doi: 10.3892/ol.2018.8948. Epub 2018 Jun 11.
2
Role of microRNAs in the main molecular pathways of hepatocellular carcinoma.微小 RNA 在肝细胞癌主要分子通路中的作用。
World J Gastroenterol. 2018 Jul 7;24(25):2647-2660. doi: 10.3748/wjg.v24.i25.2647.
3
ADAM17 promotes cell migration and invasion through the integrin β1 pathway in hepatocellular carcinoma.
生物信息学分析显示hsa_circ_0006220-miR-221/222-3p-ESR1/KDR轴与肝细胞癌索拉非尼耐药性的相关性。
Noncoding RNA Res. 2023 Nov 2;9(1):55-65. doi: 10.1016/j.ncrna.2023.11.001. eCollection 2024 Mar.
4
HCV and HCC Tango-Deciphering the Intricate Dance of Disease: A Review Article.丙型肝炎病毒和肝细胞癌的探戈舞步——疾病复杂性的解析:一篇综述文章。
Int J Mol Sci. 2023 Nov 7;24(22):16048. doi: 10.3390/ijms242216048.
5
Palmitoylation-driven PHF2 ubiquitination remodels lipid metabolism through the SREBP1c axis in hepatocellular carcinoma.棕榈酰化驱动的 PHF2 泛素化通过 SREBP1c 轴重塑肝癌中的脂质代谢。
Nat Commun. 2023 Oct 12;14(1):6370. doi: 10.1038/s41467-023-42170-0.
6
An Insight into the Arising Role of MicroRNAs in Hepatocellular Carcinoma: Future Diagnostic and Therapeutic Approaches.浅析 microRNAs 在肝细胞癌中的涌现角色:未来的诊断和治疗方法。
Int J Mol Sci. 2023 Apr 12;24(8):7168. doi: 10.3390/ijms24087168.
7
CircHECTD1 promoted MIRI-associated inflammation via inhibiting miR-138-5p and upregulating ROCK2.环状 RNA HECTD1 通过抑制 miR-138-5p 并上调 ROCK2 促进 MIRI 相关炎症。
Kaohsiung J Med Sci. 2023 Jul;39(7):675-687. doi: 10.1002/kjm2.12686. Epub 2023 Apr 25.
8
The role of AURKA/miR-199b-3p in hepatocellular carcinoma cells.AURKA/miR-199b-3p 在肝癌细胞中的作用。
J Clin Lab Anal. 2022 Dec;36(12):e24758. doi: 10.1002/jcla.24758. Epub 2022 Nov 14.
9
Dysregulation of miRISC Regulatory Network Promotes Hepatocellular Carcinoma by Targeting PI3K/Akt Signaling Pathway.miRISC 调控网络失调通过靶向 PI3K/Akt 信号通路促进肝癌。
Int J Mol Sci. 2022 Sep 25;23(19):11300. doi: 10.3390/ijms231911300.
10
Long non-coding RNA X-inactive specific transcript suppresses the progression of hepatocellular carcinoma through microRNA-221-3p-targeted regulation of O6-methylguanine-DNA methyltransferase.长链非编码 RNA X 染色体失活特异性转录本通过 microRNA-221-3p 靶向调控 O6-甲基鸟嘌呤-DNA 甲基转移酶抑制肝癌的进展。
Bioengineered. 2022 May;13(5):14013-14027. doi: 10.1080/21655979.2022.2086382.
ADAM17 通过整合素 β1 通路促进肝癌细胞迁移和侵袭。
Exp Cell Res. 2018 Sep 15;370(2):373-382. doi: 10.1016/j.yexcr.2018.06.039. Epub 2018 Jun 30.
4
Knockdown of SUMO1P3 represses tumor growth and invasion and enhances radiosensitivity in hepatocellular carcinoma.SUMO1P3 敲低抑制肝癌的肿瘤生长和侵袭并增强放射敏感性。
Mol Cell Biochem. 2019 Jan;450(1-2):125-134. doi: 10.1007/s11010-018-3379-8. Epub 2018 Jun 15.
5
Long-term prognostic impact of osteopontin and Dickkopf-related protein 1 in patients with hepatocellular carcinoma after hepatectomy.骨桥蛋白和Dickkopf相关蛋白1对肝癌肝切除术后患者的长期预后影响
Pathol Res Pract. 2018 Jun;214(6):814-820. doi: 10.1016/j.prp.2018.05.002. Epub 2018 May 6.
6
MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5.miR-106a-5p 通过靶向 PAK5 抑制肾细胞癌的细胞迁移和侵袭。
Cell Death Dis. 2017 Oct 26;8(10):e3155. doi: 10.1038/cddis.2017.561.
7
Autophagy as a potential therapeutic target during epithelial to mesenchymal transition in renal cell carcinoma: An in vitro study.自噬作为肾细胞癌上皮间质转化过程中的潜在治疗靶点:一项体外研究。
Biomed Pharmacother. 2017 Oct;94:332-340. doi: 10.1016/j.biopha.2017.07.070. Epub 2017 Jul 31.
8
Implication of PHF2 Expression in Clear Cell Renal Cell Carcinoma.PHF2表达在透明细胞肾细胞癌中的意义
J Pathol Transl Med. 2017 Jul;51(4):359-364. doi: 10.4132/jptm.2017.03.16. Epub 2017 Jun 13.
9
Identification of microRNA 885-5p as a novel regulator of tumor metastasis by targeting CPEB2 in colorectal cancer.通过靶向CPEB2鉴定微小RNA 885-5p作为结直肠癌肿瘤转移的新型调节因子
Oncotarget. 2017 Apr 18;8(16):26858-26870. doi: 10.18632/oncotarget.15844.
10
Retraction: miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells.撤回声明:miR-221促进人三阴性乳腺癌细胞的肿瘤发生。
PLoS One. 2017 Apr 10;12(4):e0175869. doi: 10.1371/journal.pone.0175869. eCollection 2017.